Association between myeloperoxidase and the risks of ischemic stroke, heart failure, and atrial fibrillation: A Mendelian randomization study
- 15 October 2022
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 33 (1) , 210-218
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 40 references indexed in Scilit:
- Global epidemiology of atrial fibrillationNature Reviews Cardiology, 2014
- Mendelian randomization: genetic anchors for causal inference in epidemiological studiesHuman Molecular Genetics, 2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Calculating statistical power in Mendelian randomization studiesInternational Journal of Epidemiology, 2012
- Chronic Heart Failure and Ischemic StrokeStroke, 2011
- Use of Myeloperoxidase for Risk Stratification in Acute Heart FailureClinical Chemistry, 2010
- Atrial Fibrillation and Heart FailureCirculation, 2009
- Usefulness of Myeloperoxidase Levels in Healthy Elderly Subjects to Predict Risk of Developing Heart FailureThe American Journal of Cardiology, 2009
- Myeloperoxidase, modified lipoproteins, and atherogenesisJournal of Lipid Research, 2009
- Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidaseProceedings of the National Academy of Sciences, 2008